Skip to content
Unrated Medical device recall · FDA · Published September 8, 2026

Nihon Kohden Central Nurse Station Software Vulnerability Recall

Nihon Kohden recalls CNS-6200 Series Central Nurse Stations with specific software versions due to cybersecurity risks that could disrupt patient monitoring systems.

🇺🇸 FDA recall #Z-0089-2027Medical deviceNihon Kohden ›
✎ GovInfoNow plain-language explainer

What happened, in plain English

Nihon Kohden is recalling certain Central Nurse Stations that could be vulnerable to cybersecurity issues. If exploited, this vulnerability might disrupt monitoring of multiple patients and alarm systems in medical facilities. Read more at govinfonow.com/recall/1629439-nihon-kohden-america-llc-recalls-product-name-nihon-kohden-cns.

Source Summary by GovInfoNow · govinfonow.com/recall/1629439-nihon-kohden-america-llc-recalls-product-name-nihon-kohden-cns · Updated October 21, 2026 · FDA enforcement record: FDA #Z-0089-2027

Cite this page

“Nihon Kohden Central Nurse Station Software Vulnerability Recall.” GovInfoNow, updated October 21, 2026. https://govinfonow.com/recall/1629439-nihon-kohden-america-llc-recalls-product-name-nihon-kohden-cns. Based on FDA recall #Z-0089-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0089-2027%22&limit=1).

Why it’s dangerous

The device has a cybersecurity vulnerability that could allow unauthorized access. If exploited, it might disrupt the monitoring of multiple patients and the visualization of alarms, potentially affecting patient safety.

Who’s affected

Medical facilities using the CNS-6200 Series Central Nurse Station with model CN-6201 and specific software versions are affected. Healthcare workers and patients in these facilities are at risk if the vulnerability is exploited.

How to tell if you have this one

Check for the model CN-6201 with software versions 01-03, 01-04, 01-05, 01-06, 02-10, 02-11, or 02-40. The product was distributed nationwide in the United States.

  • Brand
    Nihon Kohden
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Identify the software version on your Central Nurse Station to see if it matches the recalled versions.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 13 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: named in the noticeDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: nationwideTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, IL, IN. KS, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NL, NM, NV, NY, OH, OK, OR, PA, TN, TX, UT, VA, VT, QA, WA, WI, WV…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa.

Recall timeline

FDA published this recall 36 days after the firm started it.

1. Firm started the recall: Sep 8, 202612. FDA classified it Class II: Oct 6, 202623. Published in FDA’s Enforcement Report: Oct 14, 202634. Added to GovInfoNow: Oct 21, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was the product distributed?

The product was distributed nationwide in the United States, including states such as California, New York, and Texas.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0089-2027 (September 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0089-2027 to see it in context.
  • Plain-language summary written by qwen3:4b on October 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA